Why the study?
The benefit and cost-effectiveness of invasive versus medical treatment in symptomatic coronary artery disease patients aged 75 years or older was uncertain.
RCT (n=301)
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Matthias Pfisterer (2003) conducted an RCT in symptomatic coronary artery disease (n=301). Invasive strategy (coronary angiography followed by CABG or PCI) vs. Optimised medical strategy was evaluated on Critical clinical events (p=<0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: